Skip to content

Request a Sample

March 2020 MUTED-01

About EOS ^cu
Clinical Trials
EOS ^cu Industries
- Healthcare Environments
- Other Industries
EOS ^cu Partners
The Blog
What’s New
- News
- Events

About EOS ^cu
Clinical Trials
EOS ^cu Industries
- Healthcare Environments
- Other Industries
EOS ^cu Partners
The Blog
What’s New
- News
- Events

Posts by Erica Mitchell:

< 1min read.

We Will Be At 2024 CHES National Conference in Halifax, Nova Scotia!

Picture of Erica Mitchell

Erica Mitchell

Sep 5, 2024 3:59:14 PM

From September 8-10, 2024, EOS Surfaces will be attending the 2024 Canadian Healthcare Engineering...

Read more

Sales

Click here and reach out to have a member of our team contact you.

Help and Support

Need help with an EOS^CUinstallation? Let us know here.

Media and Press

Need our press kit or to contact our media team? Let us know here.

*Testing demonstrates effective antibacterial activity against Staphylococcus aureus (ATCC 6538), Enterobacter aerogenes (ATCC 13048), Methicillin-resistant Staphylococcus aureus (MRSA-ATCC 33592), Escherichia coli O157:H7 (ATCC 35150) and Pseudomonas aeruginosa (ATCC 15442).

The use of EOS^cu is a supplement to, and not a substitute for, standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfaces. EOS^cu has been shown to reduce microbial contamination but it does not necessarily prevent cross contamination. This product must not be waxed, painted, lacquered, varnished, or otherwise coated. This product must be installed by a certified EOS^cu fabricator only.

Antimicrobial EOS Surfaces^TMEPA Registration #89674-1

Contact Us
Site Map
Homepage

Copyright © 2024 EOS Surfaces

Terms of Use
Privacy Policy